Institutional investors increase stakes in Thermo Fisher, T. Rowe Price, and Transdigm

Recent SEC filings reveal significant institutional investment activity across several major corporations during the second quarter.

In the medical research sector, Thermo Fisher Scientific Inc. saw new positions from Csenge Advisory Group, valued at approximately $1.3 million, and Vise Technologies Inc., which purchased shares worth about $4.5 million. Other investors, including Swiss RE Ltd. and China Universal Asset Management Co. Ltd., also adjusted their holdings in the company.

In asset management, T. Rowe Price Group, Inc. attracted substantial new capital. Westpac Banking Corp acquired a stake valued at roughly $5.2 million, while Vise Technologies Inc. took a position worth approximately $3.9 million. Other firms, including MSH Capital Advisors LLC and Aurora Investment Counsel, also entered new positions in the firm.

Additionally, Landscape Capital Management L. L. C. established a new position in the aerospace company Transdigm Group Incorporated, purchasing 3,379 shares valued at approximately $4.5 million.